Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-022899
Filing Date
2025-08-11
Accepted
2025-08-11 07:31:15
Documents
57
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 1326164
2 EX-31.1 ex31-1.htm EX-31.1 16770
3 EX-31.2 ex31-2.htm EX-31.2 16746
4 EX-32.1 ex32-1.htm EX-32.1 7575
5 EX-32.2 ex32-2.htm EX-32.2 7613
  Complete submission text file 0001641172-25-022899.txt   6044525

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE maia-20250630.xsd EX-101.SCH 44774
7 XBRL CALCULATION FILE maia-20250630_cal.xml EX-101.CAL 39770
8 XBRL DEFINITION FILE maia-20250630_def.xml EX-101.DEF 180767
9 XBRL LABEL FILE maia-20250630_lab.xml EX-101.LAB 390540
10 XBRL PRESENTATION FILE maia-20250630_pre.xml EX-101.PRE 294015
59 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 927274
Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Filer) CIK: 0001878313 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41455 | Film No.: 251200190
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)